Microbiota and diabetes: an evolving relationship

  title={Microbiota and diabetes: an evolving relationship},
  author={Herbert Tilg and Alexander R. Moschen},
  pages={1513 - 1521}
The gut microbiota affects numerous biological functions throughout the body and its characterisation has become a major research area in biomedicine. Recent studies have suggested that gut bacteria play a fundamental role in diseases such as obesity, diabetes and cardiovascular disease. Data are accumulating in animal models and humans suggesting that obesity and type 2 diabetes (T2D) are associated with a profound dysbiosis. First human metagenome-wide association studies demonstrated highly… 

Influence of the human intestinal microbiome on obesity and metabolic dysfunction

Obesity and associated metabolic dysfunction emerge from disturbed interactions between the intestinal microbiota, dietary changes and host immune functions, which might lead to better therapies for human metabolic and inflammatory diseases in the future.

The Microbiome in Obesity, Diabetes, and NAFLD: What is Your Gut Telling Us?

Constraints in the understanding of cause- versus consequence relationships may be overcome in the future by utilizing “rationally designed” microbial consortia in small animal models.

The Role of Gut Microbiota in Obesity and Type 2 and Type 1 Diabetes Mellitus: New Insights into “Old” Diseases

This review focuses on disorders of metabolic syndrome, with special regard to obesity as a prequel to type 2 diabetes, type 2abetes itself, and type 1 diabetes, and the present state of attempts to alter the gut microbiota as a therapeutic strategy.

The gut microbiota and its interactions with cardiovascular disease

The fundamental purpose of this review was to summarize recent studies that have illustrated the complex interactions between the gut microbiota, their metabolites and the development of common CVD, as well as the effects of gut dysbiosis on CVD risk factors.

Nutrition Considerations for Microbiota Health in Diabetes

The functions of the microbiota, how it is formed, and nutritional strategies to improve gut health are reviewed, with a focus on diet and nutrition.

High-Fat Diet Changes Fungal Microbiomes and Interkingdom Relationships in the Murine Gut

A role for fungi and interkingdom interactions in the association between gut microbiomes and obesity is suggested, with evidence that ingestion of a high-fat diet is associated with changes to the fungal (and bacterial) microbiome in a mouse model.

Gut microbiota, obesity and diabetes

This review will investigate the intricate axis between the microbiota and host metabolism, while also addressing the promising and novel field of probiotics as metabolic therapies.

Metformin and gut microbiota: their interactions and their impact on diabetes

The gut microbiota of participants on metformin has exerted alterations in gut metabolomics with increased ability to produce butyrate and propionate, substances involved in glucose homeostasis, and an individual’s met formin tolerance or intolerance may be influenced by their microbiome.

Gut Microbiota: An Important Player in Type 2 Diabetes Mellitus

It is suggested that T2DM and its complications can be treated by remodeling the gut microbiota through interventions such as drugs, probiotics, prebiotics, fecal microbiota transplantation (FMT) and diets.

The gut microbiome, diet, and links to cardiometabolic and chronic disorders

Data is summarized suggesting a link between the gut microbiota and derived metabolites with food intake patterns, metabolic alterations, and chronic CMDs.



A metagenome-wide association study of gut microbiota in type 2 diabetes

MGWAS analysis showed that patients with type 2 diabetes were characterized by a moderate degree of gut microbial dysbiosis, a decrease in the abundance of some universal butyrate-producing bacteria and an increase in various opportunistic pathogens, as well as an enrichment of other microbial functions conferring sulphate reduction and oxidative stress resistance.

The role of the gut microbiota in nutrition and health

The complex interplay between the gut microbiota, diet and health is considered and better definition of those dominant commensal bacteria, community profiles and system characteristics that produce stable gut communities beneficial to health is important.

Assessing the Human Gut Microbiota in Metabolic Diseases

The use of genetically engineered gnotobiotic mouse models may increase the understanding of mechanisms by which the gut microbiome modulates host metabolism and physiology, and a combination of classical microbiology, sequencing, and animal experiments may provide further insights.

Gut Microbiota in Human Adults with Type 2 Diabetes Differs from Non-Diabetic Adults

The results of this study indicate that type 2 diabetes in humans is associated with compositional changes in intestinal microbiota and the level of glucose tolerance should be considered when linking microbiota with metabolic diseases such as obesity and developing strategies to control metabolic diseases by modifying the gut microbiota.

Human Gut Microbiota Changes Reveal the Progression of Glucose Intolerance

Evidence is provided of the structural modulation of gut microbiota in the pathogenesis of diabetes by finding that Verrucomicrobiae may be a potential marker of T2DM as it had a significantly lower abundance in both the pre-DM and T2 DM groups.

Metagenome and metabolism: the tissue microbiota hypothesis

Using germ free mice colonized with the microbiota from different origins, it has been formally demonstrated that the intestinal microbiota causes the onset of metabolic diseases and can explain the on‐going worldwide pandemic of obesity and diabetes.

Toward defining the autoimmune microbiome for type 1 diabetes

Three lines of evidence are presented that support the notion that, as healthy infants approach the toddler stage, their microbiomes become healthier and more stable, whereas, children who are destined for autoimmunity develop a microbiome that is less diverse and stable.

Gut metagenome in European women with normal, impaired and diabetic glucose control

This work uses shotgun sequencing to characterize the faecal metagenome of 145 European women with normal, impaired or diabetic glucose control, and develops a mathematical model based on metagenomic profiles that identified T2D with high accuracy.

Blood Microbiota Dysbiosis Is Associated with the Onset of Cardiovascular Events in a Large General Population: The D.E.S.I.R. Study

Pbac and Eubac were shown to be independent markers of the risk of cardiovascular disease, evidence for the new concept of the role played by blood microbiota dysbiosis on atherothrombotic disease.

Changes in Gut Microbiota Control Metabolic Endotoxemia-Induced Inflammation in High-Fat Diet–Induced Obesity and Diabetes in Mice

It is found that changes of gut microbiota induced by an antibiotic treatment reduced metabolic endotoxemia and the cecal content of LPS in both high-fat–fed and ob/ob mice, demonstrating that changes in gut microbiota controls metabolic endotoxinemia, inflammation, and associated disorders by a mechanism that could increase intestinal permeability.